Literature DB >> 21119308

Proteasome inhibitory activity of thiazole antibiotics.

Bulbul Pandit1, Uppoor G Bhat, Andrei L Gartel.   

Abstract

Thiopeptides are sulfur containing highly modified macrocyclic antibiotics with a central pyridine/tetrapyridine/dehydropiperidine ring with up to three thiazole substituents on positions 2, 3 and 6. Thiazole antibiotics with central pyridine nucleus have a macrocyclic loop connecting thiazole rings at position 2 and 3 described as ring A. In addition antibiotics with central tetrahydropyridine nucleus have a quinaldic acid macrocycle also connected to thiazole on position 2 described as ring B. We have demonstrated before that thiazole antibiotics thiostrepton and Siomycin A act as proteasome inhibitors in mammalian tumor cells. Here we decided to test whether other known thiazole antibiotics such as berninamycin, micrococcin P1 and P2, thiocillin and YM-266183 (lacking the quinaldic acid ring B) demonstrate this activity. We found that none of them act as proteasome inhibitors. Moreover, structural modification of thiostrepton to thiostrepton methyl ester (with open B ring) also did not demonstrate this activity. These data suggest that B ring of thiostrepton and Siomycin A that is absent in other thiazole antibiotics determines the proteasome inhibitory activity of these drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21119308      PMCID: PMC3047100          DOI: 10.4161/cbt.11.1.13854

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  13 in total

1.  Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1.

Authors:  Senthil K Radhakrishnan; Uppoor G Bhat; Douglas E Hughes; I-Ching Wang; Robert H Costa; Andrei L Gartel
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

2.  Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation.

Authors:  A Craiu; M Gaczynska; T Akopian; C F Gramm; G Fenteany; A L Goldberg; K L Rock
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

3.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Authors:  K L Rock; C Gramm; L Rothstein; K Clark; R Stein; L Dick; D Hwang; A L Goldberg
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

Review 4.  Proteasome inhibitors: antitumor effects and beyond.

Authors:  A Nencioni; F Grünebach; F Patrone; A Ballestrero; P Brossart
Journal:  Leukemia       Date:  2006-11-09       Impact factor: 11.528

5.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.

Authors:  Vladimir V Kalinichenko; Michael L Major; Xinhe Wang; Vladimir Petrovic; Joseph Kuechle; Helena M Yoder; Margaret B Dennewitz; Brian Shin; Abhishek Datta; Pradip Raychaudhuri; Robert H Costa
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

6.  Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.

Authors:  Michael Groll; Celia R Berkers; Hidde L Ploegh; Huib Ovaa
Journal:  Structure       Date:  2006-03       Impact factor: 5.006

7.  Novel anticancer compounds induce apoptosis in melanoma cells.

Authors:  Uppoor G Bhat; Patricia A Zipfel; Douglas S Tyler; Andrei L Gartel
Journal:  Cell Cycle       Date:  2008-06-30       Impact factor: 4.534

8.  Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin.

Authors:  Joerg M Harms; Daniel N Wilson; Frank Schluenzen; Sean R Connell; Torsten Stachelhaus; Zaneta Zaborowska; Christian M T Spahn; Paola Fucini
Journal:  Mol Cell       Date:  2008-04-11       Impact factor: 17.970

9.  L11 domain rearrangement upon binding to RNA and thiostrepton studied by NMR spectroscopy.

Authors:  Hendrik R A Jonker; Serge Ilin; S Kaspar Grimm; Jens Wöhnert; Harald Schwalbe
Journal:  Nucleic Acids Res       Date:  2006-12-14       Impact factor: 16.971

10.  Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.

Authors:  Uppoor G Bhat; Marianna Halasi; Andrei L Gartel
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more
  13 in total

Review 1.  Proteasome inhibitors: an expanding army attacking a unique target.

Authors:  Alexei F Kisselev; Wouter A van der Linden; Herman S Overkleeft
Journal:  Chem Biol       Date:  2012-01-27

Review 2.  Forkhead box M1 transcription factor: a novel target for pulmonary arterial hypertension therapy.

Authors:  Li Gu; Han-Min Liu
Journal:  World J Pediatr       Date:  2019-06-12       Impact factor: 2.764

3.  Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts.

Authors:  Ming Wang; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2011-09-08       Impact factor: 6.261

4.  A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma.

Authors:  Yen-Bin Hsu; Ming-Chin Lan; Yu-Lun Kuo; Chi-Ying F Huang; Ming-Ying Lan
Journal:  Invest New Drugs       Date:  2019-04-16       Impact factor: 3.850

5.  Saturation mutagenesis of TsrA Ala4 unveils a highly mutable residue of thiostrepton A.

Authors:  Feifei Zhang; Wendy L Kelly
Journal:  ACS Chem Biol       Date:  2015-01-20       Impact factor: 5.100

6.  Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes.

Authors:  Shuxi Qiao; Sarah D Lamore; Christopher M Cabello; Jessica L Lesson; José L Muñoz-Rodriguez; Georg T Wondrak
Journal:  Biochem Pharmacol       Date:  2012-02-01       Impact factor: 5.858

7.  Thiostrepton Variants Containing a Contracted Quinaldic Acid Macrocycle Result from Mutagenesis of the Second Residue.

Authors:  Feifei Zhang; Chaoxuan Li; Wendy L Kelly
Journal:  ACS Chem Biol       Date:  2015-12-14       Impact factor: 5.100

Review 8.  YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function.

Authors:  Brandon J Burkhart; Christopher J Schwalen; Greg Mann; James H Naismith; Douglas A Mitchell
Journal:  Chem Rev       Date:  2017-03-03       Impact factor: 60.622

9.  Thiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells.

Authors:  Bulbul Pandit; Andrei L Gartel
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

Review 10.  Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors.

Authors:  Andrei L Gartel
Journal:  Scientifica (Cairo)       Date:  2014-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.